Connecticut Overdose Reporting Privacy Laws: What EDs Need to Know When Documenting Naloxone Reversals in State Dashboards

Naloxone Distribution and Availability in Connecticut

Where patients and caregivers can obtain naloxone

In Connecticut, naloxone is widely available through pharmacies and community programs. Pharmacists may dispense opioid antagonists under medical protocol standing orders, and some naloxone products are available over the counter without a prescription. These pathways expand access for patients at risk and for family or bystanders positioned to assist. ([prdext2.cga.ct.gov](https://prdext2.cga.ct.gov/2026/sup/chap_400j.htm?utm_source=openai))

Connecticut’s Good Samaritan protections reduce legal risk for people who, in good faith, seek emergency help or administer naloxone during an overdose. The goal is to encourage rapid 911 calls and lifesaving intervention without fear of arrest for simple possession. ([cga.ct.gov](https://www.cga.ct.gov/2024/rpt/pdf/2024-R-0085.pdf?utm_source=openai))

What emergency departments should know

State partners have supported hospital participation in naloxone distribution, including initiatives that equip EDs to dispense take-home naloxone at discharge. Aligning ED workflows with these efforts improves linkage to harm-reduction resources and treatment. ([portal.ct.gov](https://portal.ct.gov/dmhas/newsworthy/press-releases-2019/state-provides-hospital-emergency-departments-with-naloxone?utm_source=openai))

EMS protocols in Connecticut also authorize leave-behind naloxone kits after overdose encounters and ask crews to document kit distribution in the ePCR. Understanding what arrives with patients—pre-hospital naloxone use, dosage, and response—helps ED teams complete accurate naloxone reversal documentation for state dashboards. ([portal.ct.gov](https://portal.ct.gov/dph/-/media/departments-and-agencies/dph/dph/ems/pdf/statewide_protocols/2025/v20251_ctemsstatewideprotocolsfinal.pdf?hash=75800443C0145E31048FAEA7CDC6095D&rev=965b641da11542d3ae205d6922d0f527&utm_source=openai))

Implementation of the SWORD Program

How SWORD works

The Connecticut EMS Statewide Opioid Reporting Directive (SWORD) is a real-time system that requires EMS clinicians to report suspected opioid overdoses—whether or not naloxone was given—to the Connecticut Poison Control Center (CPCC). SWORD facilitates rapid surveillance and early warnings for spikes in overdoses. ([portal.ct.gov](https://portal.ct.gov/dph/emergency-medical-services/ems/oems---sword?utm_source=openai))

SWORD data are integrated with the Overdose Detection Mapping Application Program (ODMAP) to visualize events and trigger alerts. During overdose clusters, DPH epidemiologists corroborate SWORD with ED syndromic surveillance and medical examiner data to guide local response. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC8573789/?utm_source=openai))

Rollout and current status

OEMS implemented SWORD statewide in 2019 via regional phases and ongoing communications. Regular newsletters and annual reports summarize trends, methods, and program refinements for field and hospital partners. ([portal.ct.gov](https://portal.ct.gov/dph/emergency-medical-services/ems/ems-communications-and-reference-documents?utm_source=openai))

EMS Reporting Requirements for Opioid Overdoses

Who must report and when

Under CGS § 19a-127q, EMS personnel who treat a patient for an opioid overdose must report the event to the Department of Public Health (DPH) in the form and manner the Commissioner prescribes. In practice, SWORD operationalizes this requirement through immediate reporting to the CPCC following suspected overdose calls. ([law.justia.com](https://law.justia.com/codes/connecticut/title-19a/chapter-368a/section-19a-127q/?utm_source=openai))

What information is captured

Connecticut’s SWORD dataset captures key prehospital elements, including whether naloxone was administered, who administered it (bystander, EMS, law enforcement), and the patient’s transport disposition—data that flow to state dashboards and ODMAP. ED teams should ensure continuity by reconciling prehospital naloxone details in the medical record. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC13246212/?utm_source=openai))

Hospital Reporting and Mental Health Screening

Overdose reporting by hospitals

Hospitals are also required to report opioid overdoses to DPH in a manner prescribed by the Commissioner. This statutory obligation has been in effect since January 1, 2019, and complements EMS reporting to give the state a fuller view of overdose incidents. ([law.justia.com](https://law.justia.com/codes/connecticut/title-19a/chapter-368a/section-19a-127q/?utm_source=openai))

Mental health screening after nonfatal overdose

Effective January 1, 2020, hospitals that treat a patient for a nonfatal opioid overdose must administer a mental health screening or assessment when medically appropriate and provide the results to the patient (or guardian, as applicable). Building this step into the ED care pathway is a core Legal Requirement for ED Reporting and post-overdose care. ([cga.ct.gov](https://www.cga.ct.gov/2019/act/Pa/pdf/2019PA-00191-R00HB-07159-PA.PDF?utm_source=openai))

Toxicology screening and DPH reporting (2025 onward)

As of January 1, 2025, Public Act 24-120 requires hospitals to share toxicology screening results for suspected drug overdose patients with DPH if screening is medically appropriate and the patient consents. The act identifies a baseline test panel and directs DPH to analyze results and report trends to the legislature. ([portal.ct.gov](https://portal.ct.gov/dph/health-education-management--surveillance/the-office-of-injury-prevention/opioids-and-prescription-drug-overdose-prevention-program))

Data Confidentiality and Privacy Protections

Confidentiality under Connecticut law

Overdose data reported to DPH under CGS § 19a-127q “shall at all times remain confidential” under CGS § 19a-25 and are used only for medical or scientific research and for disease control and prevention. These records are generally not subject to public disclosure and are not admissible as evidence in court. ([law.justia.com](https://law.justia.com/codes/connecticut/title-19a/chapter-368a/section-19a-127q/?utm_source=openai))

HIPAA and public health reporting

DPH conducts these activities as public health surveillance; shared guidance clarifies how overdose surveillance and ODMAP can operate under HIPAA’s public health framework while limiting identifiable data to the minimum necessary. EDs should document and disclose in accordance with DPH’s prescribed reporting methods and their own HIPAA policies. ([portal.ct.gov](https://portal.ct.gov/dph/emergency-medical-services/ems/oems---sword?utm_source=openai))

Data Sharing with Local Health Departments

What is shared and why

DPH provides overdose data to municipal and district health departments with jurisdiction over the overdose location (or treatment site, if the location is unknown) to support local prevention initiatives. This provision has been in effect since January 1, 2020, and operates within the same confidentiality safeguards. ([law.justia.com](https://law.justia.com/codes/connecticut/title-19a/chapter-368a/section-19a-127q/?utm_source=openai))

Aggregation and dashboards

Aggregated, de-identified trends may appear in public-facing summaries and dashboards (e.g., SWORD newsletters), but identifiable data remain protected. Hospitals should coordinate with their local health departments to align outreach, education, and naloxone distribution strategies based on shared trend data. ([portal.ct.gov](https://portal.ct.gov/-/media/departments-and-agencies/dph/dph/ems/pdf/sword/sword-newsletters/2024/swordsept2024nl_final.pdf?hash=DDA0CF27957D13A810C276C10AA3B341&rev=b8228819fbdb4bdf851b5b98b73e3fe5&utm_source=openai))

Compliance Strategies for Emergency Departments

Build a reliable reporting workflow

• Map where overdose documentation lives in your EHR (triage, ED course, med admin record) and ensure it feeds your Department of Public Health Reporting interface “in the form and manner prescribed.” ([law.justia.com](https://law.justia.com/codes/connecticut/title-19a/chapter-368a/section-19a-127q/?utm_source=openai))
• Standardize a Naloxone Reversal Documentation template that captures dose, route, timing, response, prehospital naloxone (including bystander), and final disposition. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC13246212/?utm_source=openai))
• Coordinate with your EMS partners on SWORD Program Compliance so ED documentation reconciles with the SWORD call made from the scene. ([portal.ct.gov](https://portal.ct.gov/dph/emergency-medical-services/ems/oems---sword?utm_source=openai))

Embed required screenings and consents

• Hardwire Mental Health Screening Protocols for all medically appropriate nonfatal overdoses, including delivery of results to the patient or guardian. ([cga.ct.gov](https://www.cga.ct.gov/2024/ba/pdf/2024HB-05291-R000105-BA.pdf?utm_source=openai))
• From January 1, 2025, incorporate consent and workflow for toxicology screening and ensure timely submission of results to DPH; confirm your lab panel aligns with the state’s minimum test list. ([cga.ct.gov](https://www.cga.ct.gov/olr/Documents/year/PASUMBK/2024PASUMBK-20241001_Summary%20of%202024%20Public%20Acts.pdf?utm_source=openai))

Protect privacy and minimize risk

• Audit reports for the minimum necessary PHI, verify destination endpoints, and maintain records consistent with CGS § 19a-25 confidentiality requirements. ([cga.ct.gov](https://cga.ct.gov/2025/pub/chap_368a.htm?utm_source=openai))
• Train staff on the Connecticut EMS Opioid Reporting Directive, overdose data confidentiality, and internal escalation paths for privacy questions. ([portal.ct.gov](https://portal.ct.gov/dph/emergency-medical-services/ems/oems---sword?utm_source=openai))

Strengthen linkage to harm reduction and care

• Offer take-home naloxone at discharge and document education provided; coordinate with community programs and local health departments for follow-up and supply. ([portal.ct.gov](https://portal.ct.gov/dmhas/newsworthy/press-releases-2019/state-provides-hospital-emergency-departments-with-naloxone?utm_source=openai))
• Track referrals to treatment and recovery supports; use shared dashboards to identify repeat utilizers and tailor outreach. ([portal.ct.gov](https://portal.ct.gov/dph/health-education-management--surveillance/the-office-of-injury-prevention/opioid-and-drug-overdose-statistics?utm_source=openai))

Summary

For ED leaders, compliance hinges on three pillars: complete and timely overdose reporting, documented mental health and toxicology screening where required, and rigorous protection of patient privacy. Align your EHR templates and workflows with SWORD-adjacent data elements, maintain CGS § 19a-25 confidentiality, and partner with EMS and local health departments to turn naloxone reversal documentation into better prevention and care. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC13246212/?utm_source=openai))

FAQs.

What are the specific privacy requirements for overdose data reporting in Connecticut?

Overdose data reported to DPH under CGS § 19a-127q are confidential under CGS § 19a-25. They are used solely for medical or scientific research and disease prevention/control, are generally not subject to public disclosure, and are not admissible as evidence in court proceedings. EDs should transmit only what DPH prescribes and apply the minimum-necessary standard. ([law.justia.com](https://law.justia.com/codes/connecticut/title-19a/chapter-368a/section-19a-127q/?utm_source=openai))

How must emergency departments document naloxone reversals under state law?

Hospitals must report each opioid overdose to DPH “in a form and manner prescribed by the Commissioner.” Practically, your ED record should capture naloxone administration (prehospital and in-ED), dose, route, timing, patient response, and disposition so the required elements flow to state dashboards and reconcile with EMS SWORD data. From January 1, 2025, share toxicology results with DPH when screening is performed with consent. ([law.justia.com](https://law.justia.com/codes/connecticut/title-19a/chapter-368a/section-19a-127q/?utm_source=openai))

Who has access to opioid overdose data reported to the Department of Public Health?

DPH maintains the data for surveillance and may provide it to the municipal or district health department with jurisdiction over the overdose location (or treatment site if the location is unknown) to support local prevention. Aggregated trends may appear in public summaries, but identifiable data remain protected by law. ([law.justia.com](https://law.justia.com/codes/connecticut/title-19a/chapter-368a/section-19a-127q/?utm_source=openai))

What mental health screening is required after a nonfatal opioid overdose?

Connecticut law requires hospitals, when medically appropriate, to administer a mental health screening or assessment after a nonfatal opioid overdose and provide the results to the patient (or guardian, as applicable). Embedding a standardized screening step in ED pathways ensures compliance and supports safer discharge planning. ([cga.ct.gov](https://www.cga.ct.gov/2019/act/Pa/pdf/2019PA-00191-R00HB-07159-PA.PDF?utm_source=openai))